NEW YORK (GenomeWeb News) – Direct-to-consumer genomics firm 23andMe today announced it has raised an additional $9 million in its Series C financing round, bringing the total funding in the round to $31 million.
MPM Capital joined Johnson & Johnson Development Corp. as a new investor, the Mountain View, Calif.-based firm said. Ashley Ledbetter Dombkowski, a director at MPM, is joining 23andMe's board, it added.